Evidence map›Paper›PMID 35231992›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2022

[MYC and BCL-2 protein co-expression and prognosis of patients with diffuse large B-cell lymphoma: a propensity score matching analysis].

J Zhan, S J Yang, W Zhang, D B Zhou, Y Zhang, W Wang, C Wei

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J ZhanDepartment of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.
S J YangDepartment of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.
W ZhangDepartment of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.
D B ZhouDepartment of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.
Y ZhangDepartment of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.
W WangDepartment of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.
C WeiDepartment of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Beijing Natural Science Foundation 7202154Chinese Academy of Medical Sciences Medical and Health Science & Technology Innovation Project 2016-I2M-1-001Natinal Natural Science Foundtion of China 81970188
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsLymphoma, Large B-Cell, DiffuseDoxorubicinHumansPrognosisPropensity ScoreProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycRetrospective StudiesRituximabVincristineBCL2 protein, humanDoxorubicinMYC protein, humanProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycRituximabVincristineBCL-2Lymphoma, large B cell, diffuseMYCPrognosisPropensity score matching

Identifiers

PMID35231992
PMCPMC8980659
OpenAlexW4214852581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.